Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

N30 Pharma's GSNOR inhibitors show promise for the treatment of asthma

April 1, 2011

Omalizumab data in food allergy, urticaria, atopic dermatitis and geriatric asthma reported

April 1, 2011

OriBase Pharma identifies agent for BCR/ABL T315I mutant CML

March 31, 2011

New dual LFA-1/MAC-1 antagonists presented by Roche at the ACS meeting

March 31, 2011

Merck & Co. presents new glucagon receptor antagonist for type 2 diabetes

March 31, 2011

Pfizer targets IRAK-4 for autoimmune diseases

March 30, 2011

BMS-520 identified as a potent and selective S1P1 receptor agonist

March 30, 2011

MP-29-02 associated with significant improvements in symptoms of allergic rhinitis

March 30, 2011

Nicardipine shows promise in study in subjects with Peyronie's disease / News in Context

March 30, 2011

Phase II data show reduced late asthmatic response with lebrikizumab treatment

March 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...